Target Details
| UniProt AC | Q13546 |
|---|---|
| Gene Symbol | RIPK1 |
| Protein Name | Receptor-interacting serine/threonine-protein kinase 1 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00531 (Death) PF07714 (PK_Tyr_Ser-Thr) |
Summary
- Multi-target molecules 315
- Clinical molecules 6
- Avg pChEMBL 8.13
KEGG Pathways (16)
- Alcoholic liver disease
- Apoptosis
- Cytosolic DNA-sensing pathway
- Epstein-Barr virus infection
- Hepatitis C
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- NF-kappa B signaling pathway
- NOD-like receptor signaling pathway
- Necroptosis
- Pathogenic Escherichia coli infection
- RIG-I-like receptor signaling pathway
- Salmonella infection
- Shigellosis
- TNF signaling pathway
- Toll-like receptor signaling pathway
Associated Diseases (2)
Active Molecules (315)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
OZMDCWDZDUUPCT
|
9.7 | IC50 | 2 | — | |
PTBKRKJDZJIGMO
|
9.7 | IC50 | 2 | — | |
XVIRXUBIUWTIAU
|
9.7 | IC50 | 2 | — | |
DSKYHEJWWIBREA
|
9.6 | Kd | 8 | — | |
WGLQAYNJIFOANO
|
9.5 | IC50 | 2 | — | |
WXNOXFAWDUEBAQ
|
9.5 | IC50 | 2 | — | |
YQWFKLQPKYCJDE
|
9.5 | IC50 | 2 | — | |
DJVBTTBJGKUASK
|
9.4 | IC50 | 2 | — | |
GPXNCTKGLKXRLY
|
9.4 | IC50 | 2 | — | |
GVNGLGMOHLFLJG
|
9.4 | IC50 | 2 | — | |
NKNSMRWBHMCQTM
|
9.4 | IC50 | 2 | — | |
POZSHWOJVWWMON
|
9.4 | IC50 | 2 | — | |
XZBGRGYKTKCJDO
|
9.4 | IC50 | 2 | — | |
IUSXFQNTDSJZSX
|
9.3 | IC50 | 2 | — | |
MLULYTTTYREQGB
|
9.3 | IC50 | 2 | — | |
TZXYDNQUSBJURA
|
9.3 | IC50 | 2 | — | |
XYVQOYARHKRTFN
|
9.3 | IC50 | 2 | — | |
UGTLDBJIOSYXRR
|
9.3 | IC50 | 2 | — | |
GRNPQAUIFHUTSP
|
9.3 | IC50 | 2 | — | |
GPXNCTKGLKXRLY
|
9.2 | IC50 | 2 | — | |
IQUQHZXCHBDAAW
|
9.2 | IC50 | 2 | — | |
KNIULYCUWOGHSI
|
9.2 | IC50 | 2 | — | |
LVGZUKBSCYYWMC
|
9.2 | IC50 | 2 | — | |
MEIRWDCGNCYHGJ
|
9.2 | IC50 | 2 | — | |
MEIRWDCGNCYHGJ
|
9.2 | IC50 | 2 | — | |
MRYPBXQDXGBARZ
|
9.2 | IC50 | 2 | — | |
SYZZNLUQYKUJAD
|
9.2 | IC50 | 2 | — | |
DKNKEEKATVDSMP
|
9.2 | IC50 | 2 | — | |
IDYWYWMLLZTBSA
|
9.2 | IC50 | 2 | — | |
PENDQBTWOLHSKH
|
9.2 | IC50 | 2 | — | |
PKHQKYDPPNNWGZ
|
9.2 | IC50 | 2 | — | |
KHVVJKLNKLQLJZ
|
9.1 | IC50 | 288 | — | |
TZXYDNQUSBJURA
|
9.1 | IC50 | 2 | — | |
RCLQRRIIUCBMPX
|
9.1 | IC50 | 2 | — | |
SYZZNLUQYKUJAD
|
9.1 | IC50 | 2 | — | |
TZXYDNQUSBJURA
|
9.1 | IC50 | 2 | — | |
WTNYOVMWJWLLIQ
|
9.1 | IC50 | 2 | — | |
FNRCSGQLGPGABP
|
9.1 | IC50 | 2 | — | |
ASFRLTODYTWPAU
|
9.1 | IC50 | 2 | — | |
CNYNPLQCTPSHJT
|
9.1 | IC50 | 2 | — | |
NKNSMRWBHMCQTM
|
9.1 | IC50 | 2 | — | |
NXCZMDQVFMPBOI
|
9.1 | IC50 | 2 | — | |
PTBKRKJDZJIGMO
|
9.1 | IC50 | 2 | — | |
RCLQRRIIUCBMPX
|
9.1 | IC50 | 2 | — | |
SQJPCTAGKZBIIZ
|
9.1 | IC50 | 2 | — | |
SQJPCTAGKZBIIZ
|
9.1 | IC50 | 2 | — | |
WTNYOVMWJWLLIQ
|
9.1 | IC50 | 2 | — | |
ZUOVJSWGLBRILC
|
9.1 | IC50 | 2 | — | |
AVNYULWTERJTEY
|
9.0 | IC50 | 2 | — | |
BJFBPNGRSOTUNJ
|
9.0 | IC50 | 2 | — |